Vancomycin utilization at a teaching hospital in Hong Kong

被引：6

作者：

You, JHS ^{[1
]}

Lyon, DJ

Lee, BSC

Kwan, SM

Tang, HY

机构：

[1] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Shatin, Hong Kong, Peoples R China

[2] Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China

[3] Prince Wales Hosp, Dept Pharm, Hong Kong, Hong Kong, Peoples R China

[4] Hosp Author, Hong Kong, Hong Kong, Peoples R China

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2001年 / 58卷 / 22期

关键词：

D O I：

10.1093/ajhp/58.22.2167

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：2167 / 2169

页数：3

共 7 条

[1]

*HOSP INF CONTR PR, 1995, MMWR-MORBID MORTAL W, V44, P1

[2] INAPPROPRIATE VANCOMYCIN PRESCRIBING BASED ON CRITERIA FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION [J].

JOHNSON, SV ;

HOEY, LL ;

VANCEBRYAN, K .

PHARMACOTHERAPY, 1995, 15 (05) :579-585

[3] First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital [J].

Ploy, MC ;

Grélaud, C ;

Martin, C ;

de Lumley, L ;

Denis, F .

LANCET, 1998, 351 (9110) :1212-1212

[4] Bacteremia caused by staphylococci with inducible vancomycin heteroresistance [J].

Wong, SSY ;

Ho, PL ;

Woo, PCY ;

Yuen, KY .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) :760-767

[5]

1997, MMWR, V46, P813

[6]

2000, MMWR, V48, P1165

[7]

1997, MMWR, V46, P624

← 1 →